Bevacizumab Use in Patients With Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825 Conference

cited authors

  • Hall, WA; Pugh, SL; Gilbert, MR; Wefel, JS; Armstrong, T; Wendland, MM; Brachman, DG; Roof, KS; Brown, PD; Crocker, IR; Robins, HI; Lee, RJ; Chao, ST; Kim, L; Srkalovic, G; Fisch, BM; Mehta, MP; Curran, WJ; Movsas, B

fiu authors

publication date

  • November 1, 2015


  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology


  • San Antonio, TX

Digital Object Identifier (DOI)


  • 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)

start page

  • S110

end page

  • S110


  • 93


  • 3